WayPoint Biomedical, Inc. Signs LOI With System Two In Australia For Homeland Defense Explosive Tests
WayPoint Biomedical, Inc. (OTC: WYPH) is pleased to announce that they have signed an LOI with Australia-based System Two Pty Ltd. to discuss and potentially enter into an "exclusive" licensing agreement for the System Two Frontline® Dry Chemistry Explosive Test Kit range, along with their new proprietary Alcohol Test Kits.